Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging
暂无分享,去创建一个
E. Teng | G. Cole | P. Chan | S. Frautschy | Fusheng Yang | Ping-ping Chen | O. Ubeda | F. Nothias | Q. Ma | Mher Alaverdyan | X. Zuo | Dana J. Gant | Nicolae C Kiosea | Sean Nazari | Qiu-lan Ma
[1] R. Bazinet,et al. Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats[S] , 2013, Journal of Lipid Research.
[2] Dana Waichunas,et al. A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease , 2013, Journal of Alzheimer's disease : JAD.
[3] W. Harris,et al. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. , 2013, Nutrition reviews.
[4] Meaghan Morris,et al. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice , 2013, Neurobiology of Aging.
[5] E. Capetillo-Zarate,et al. Accumulation of Intraneuronal β-Amyloid 42 Peptides Is Associated with Early Changes in Microtubule-Associated Protein 2 in Neurites and Synapses , 2013, PloS one.
[6] A. Ittner,et al. Lessons from Tau-Deficient Mice , 2012, International journal of Alzheimer's disease.
[7] Blaine R. Roberts,et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.
[8] F. Cicchetti,et al. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease , 2011, Journal of Lipid Research.
[9] L. Packer,et al. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling , 2010, Journal of clinical biochemistry and nutrition.
[10] G. Cole,et al. Dietary fatty acids and the aging brain. , 2010, Nutrition reviews.
[11] Michael Weiner,et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.
[12] S. Rapoport,et al. Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA2β (VIA)-deficient mice , 2010, Journal of Lipid Research.
[13] D. Wilcock,et al. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.
[14] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[15] B. Ames. Optimal micronutrients delay mitochondrial decay and age-associated diseases , 2010, Mechanisms of Ageing and Development.
[16] G. Garden,et al. A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia , 2010, Journal of visualized experiments : JoVE.
[17] Zhiyong Zhang,et al. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease , 2009, Journal of the Neurological Sciences.
[18] H. Vinters,et al. β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.
[19] G. Cole,et al. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals , 2009, Neurobiology of Disease.
[20] R. Wade-Martins,et al. Knock-out and transgenic mouse models of tauopathies , 2009, Neurobiology of Aging.
[21] Shih-Yi Huang,et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[22] C. Cotman,et al. Inflammatory changes parallel the early stages of Alzheimer disease , 2007, Neurobiology of Aging.
[23] Y. von Boxberg,et al. Extensive structural remodeling of the injured spinal cord revealed by phosphorylated MAP1B in sprouting axons and degenerating neurons , 2007, The European journal of neuroscience.
[24] L. Buée,et al. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. , 2007, The American journal of pathology.
[25] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[26] B. Riederer,et al. Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein , 2007, Brain Research Bulletin.
[27] G. Collingridge,et al. LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β , 2007, Neuron.
[28] T. Montine,et al. Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice , 2007, Neurobiology of Aging.
[29] S. Halpain,et al. The MAP1 family of microtubule-associated proteins , 2006, Genome Biology.
[30] R. Berry,et al. Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.
[31] B. Teter,et al. Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro , 2006 .
[32] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[33] Jeppe Falsig,et al. Progressive Degeneration of Human Mesencephalic Neuron-Derived Cells Triggered by Dopamine-Dependent Oxidative Stress Is Dependent on the Mixed-Lineage Kinase Pathway , 2005, The Journal of Neuroscience.
[34] Takashi Morihara,et al. A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.
[35] P. Marsh,et al. Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons , 2005, Journal of Cell Science.
[36] G. Pigino,et al. Polyglutamine expansion diseases: failing to deliver. , 2005, Trends in molecular medicine.
[37] Chi Li,et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Halpain,et al. The MAP2/Tau family of microtubule-associated proteins , 2004, Genome Biology.
[39] Takashi Morihara,et al. Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.
[40] R. Rissman,et al. Biochemical analysis of GABAA receptor subunits α1, α5, β1, β2 in the hippocampus of patients with Alzheimer's disease neuropathology , 2003, Neuroscience.
[41] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] George Perry,et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.
[43] M. Mesulam,et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.
[44] Mark Ellisman,et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. , 2003, Developmental cell.
[45] P. Adlard,et al. Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease , 2002, Acta Neuropathologica.
[46] B. Ames,et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] Z. Bashir,et al. Long-term depression: a cascade of induction and expression mechanisms , 2001, Progress in Neurobiology.
[48] N. Hirokawa,et al. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization , 2001, The Journal of cell biology.
[49] S. Hossain,et al. Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.
[50] M. Vitek,et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.
[51] S. Lovestone,et al. Neurofibrillary tangles and tau phosphorylation. , 2001, Biochemical Society symposium.
[52] L. Martin,et al. N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease , 2001, Journal of the Neurological Sciences.
[53] C. Kessler,et al. Brain plasticity: to what extent do aged animals retain the capacity to coordinate gene activity in response to acute challenges , 2000, Experimental Gerontology.
[54] N. Hirokawa,et al. Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes , 2000, The Journal of cell biology.
[55] N. Hirokawa,et al. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. , 2000, Science.
[56] J. Ávila,et al. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function , 2000, Progress in Neurobiology.
[57] W. Blackstock,et al. Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry , 2000, Journal of neurochemistry.
[58] J. Ávila,et al. GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. , 2000, European journal of cell biology.
[59] N. Hirokawa,et al. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.
[60] Bin Zhang,et al. Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.
[61] R. Goold,et al. Glycogen synthase kinase 3 β phosphorylation of microtubule-associated protein 1 B regulates the stability of microtubules in growth cones , 1999 .
[62] G. Jicha,et al. A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.
[63] I. Fischer,et al. Localisation of Microtubule‐Associated Protein 1B Phosphorylation Sites Recognised by Monoclonal Antibody SMI‐31 , 1997, Journal of neurochemistry.
[64] J. Brion,et al. Reduction of Acetylated α-Tubulin Immunoreactivity in Neurofibrillary Tangle-bearing Neurons in Alzheimer's Disease , 1996 .
[65] J. Brion,et al. Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. , 1996, Journal of neuropathology and experimental neurology.
[66] Alejandra del C. Alonso,et al. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.
[67] K. Kosik,et al. MAP-1B/TAU functional redundancy during laminin-enhanced axonal growth. , 1996, Journal of cell science.
[68] J. Ávila,et al. Variations in in vivo phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. , 1995, The Biochemical journal.
[69] J. Ávila,et al. Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. , 1994, Brain research. Molecular brain research.
[70] N. Hirokawa,et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.
[71] J. Ávila,et al. Role of phosphorylated MAPIB in neuritogenesis , 1994 .
[72] D. Platt,et al. Dynamics of gene expression for microtubule-associated protein MAP1B, embryonic α-tubulin and late neural β-tubulin mRNAs in the hippocampus of aged rats , 1992 .
[73] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[74] J. Denny. MAP5 in cultured hippocampal neurons: Expression diminishes with time and growth cones are not immunostained , 1991, Journal of neurocytology.
[75] M. Hasegawa,et al. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease , 1990, Neuron.
[76] R. Vallee,et al. MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[77] A. Matus,et al. Developmental regulation of two microtubule-associated proteins (MAP2 and MAP5) in the embryonic avian retina. , 1987, Development.
[78] G. Bloom,et al. Microtubule-associated protein 1B: identification of a major component of the neuronal cytoskeleton. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[79] R. Morris. Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.
[80] B. Teter,et al. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. , 2006, Journal of Neuroscience Research.
[81] J. Ávila,et al. Altered levels of microtubule proteins in brains of Alzheimer's disease patients , 2004, Acta Neuropathologica.
[82] R. Rissman,et al. Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology. , 2003, Neuroscience.
[83] T. Shirao,et al. Disappearance of actin‐binding protein, drebrin, from hippocampal synapses in alzheimer's disease , 1996, Journal of neuroscience research.
[84] J. Ávila,et al. Role of phosphorylated MAPlB in neuritogenesis. , 1994, Cell biology international.
[85] D. Platt,et al. Dynamics of gene expression for microtubule-associated protein MAP1B, embryonic alpha-tubulin and late neural beta-tubulin mRNAs in the hippocampus of aged rats. , 1992, Biochemical and Biophysical Research Communications - BBRC.
[86] S. Young,et al. Neuronal Fibrillar Cytoskeleton and Endomembrane System Organization in Alzheimer’s Disease , 1987 .